Juan I Arostegui Selected Research

Pyogenic arthritis, pyoderma gangrenosum, and acne

1/2022	Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1.
11/2015	Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan I Arostegui Research Topics

Disease

4	Familial Mediterranean Fever (Periodic Disease) 01/2022 - 01/2004
3	Inflammation (Inflammations) 01/2017 - 11/2015
3	Fever (Fevers) 01/2017 - 01/2004
2	Pyogenic arthritis, pyoderma gangrenosum, and acne 01/2022 - 11/2015
2	Uveitis 01/2018 - 05/2015
2	Cryopyrin-Associated Periodic Syndromes 11/2015 - 08/2014
1	Central Nervous System Vasculitis 01/2022
1	Enterocolitis 01/2022
1	Macrophage Activation Syndrome 01/2022
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2022
1	Gout 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Arthritis (Polyarthritis) 01/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019
1	Atherosclerosis 01/2019
1	Panuveitis 01/2018
1	Schnitzler Syndrome 01/2018
1	Hereditary Autoinflammatory Diseases 01/2018
1	Multifocal Choroiditis 01/2018
1	Skin Diseases (Skin Disease) 12/2017
1	Cardiac Tamponade 04/2017
1	Pericarditis 04/2017
1	autosomal dominant familial Periodic fever 04/2017
1	Mevalonate Kinase Deficiency 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2016
1	hyperzincemia and hypercalprotectinemia 11/2015
1	Polycythemia (Erythrocytosis) 06/2015
1	Primary Myelofibrosis (Myelosclerosis) 06/2015
1	Pain (Aches) 06/2015
1	Blau syndrome 05/2015
1	Hydrarthrosis 02/2008
1	Palindromic rheumatism 08/2007

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2022 - 07/2016
4	PyrinIBA 01/2022 - 06/2015
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2014
3	InflammasomesIBA 01/2022 - 07/2016
2	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2018
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018 - 04/2017
2	canakinumab FDA Link 01/2017 - 11/2015
2	Colchicine FDA LinkGeneric 06/2015 - 01/2004
1	InterferonsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	NLR ProteinsIBA 01/2019
1	Rheumatoid FactorIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	Interleukin-1 (Interleukin 1)IBA 01/2018
1	Caspase 1 (ICE Protease)IBA 07/2016
1	InterleukinsIBA 07/2016
1	Messenger RNA (mRNA)IBA 07/2016
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2016
1	C-Reactive ProteinIBA 03/2016
1	Proline (L-Proline)FDA Link 11/2015
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2015
1	AlarminsIBA 11/2015
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2015
1	DNA (Deoxyribonucleic Acid)IBA 06/2015
1	Janus Kinase 2IBA 06/2015
1	ametantrone (HAQ)IBA 06/2015
1	Retinaldehyde (Retinal)IBA 05/2015
1	Calcium PyrophosphateIBA 02/2008
1	Anti-Citrullinated Protein AntibodiesIBA 08/2007
1	AA amyloidosisIBA 01/2004

Therapy/Procedure

1	Immunomodulation 01/2018
1	Therapeutics 01/2018
1	Lasers (Laser) 06/2015